Corcept Therapeutics Inc (CORT)
51.28
-0.38
(-0.74%)
USD |
NASDAQ |
Jan 07, 16:00
51.28
0.00 (0.00%)
After-Hours: 16:33
Corcept Therapeutics Research and Development Expense (Annual): 184.35M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ADMA Biologics Inc | 3.30M |
| Catalyst Pharmaceuticals Inc | 93.15M |
| Madrigal Pharmaceuticals Inc | 272.35M |
| ACADIA Pharmaceuticals Inc | 351.62M |
| Ionis Pharmaceuticals Inc | 899.62M |